Driving Exploration of 3D Protein Structures for Drug Discovery & Development

The Structure-Based Drug Design Summit Begins in...


Welcome to the Inaugural Structure-Based Drug Design Summit

Harnessing Integrative Structural Biology Techniques Including NMR, X-Ray Crystallography, Cryo-EM, & Cryo-ET to Determine 3D Structures of Pharmacologically Relevant Targets & Propel Drug Design

Have you heard the boom created by Cryo-EM? Drug development has been shaken up with the application of Cryo-EM, accelerating and increasing the rate of success of protein targeting by identifying new ways to treat diseases with greater sensitivity and efficiency in the study of 3D structures. Structural biologists, medicinal chemists, and computational chemists need to assess the experimental methods by sharing case study presentations to streamline, rationalize, and optimize drug design.

The inaugural Structure-Based Drug Design Summit is your opportunity to assess the resolution and speed of the techniques in the toolbox to answer structural biology questions for drug design, assess the gaps, and implement newer techniques for increased specificity and precision

Sharing cutting-edge structural biology methods and applications, including harnessing Cryo-EM and Cryo-ET to visualize protein interactions, structure-based methods as a package of techniques to study integrated biological systems, and incorporating computational methods as a predictive tool for structures; this is a unique opportunity to come together and rationalize drug design by understanding the 3D structure of proteins. Join 50+ industry scientists to delve into 3D protein structure determination using NMR, X-Ray Crystallography, Cryo-EM, and Cryo-ET, to improve resolution and efficiency and rationalize drug development.

Revolutionize the way drugs are discovered and developed to lead to newer and more effective therapeutics for a wide range of diseases, build the complete 3D picture, and go after undruggable targets.

Join 50+ Industry Structural Biology, Drug Discovery, Drug Design, Experts with Job Titles including:

Associate Director – Data Science & Investigator | Associate Principal Scientist | Chief Executive Officer & Co-Founder | Director, Protein Science & Structural Biology | Director, Structural Biology, Biochemistry & Chemical Biology | Executive Director | Group Leader | Head of Structural Biology Laboratory | Head of Structural Sciences, Molecular Modelling & Chemoinformatics | Principal Scientist | Professor | Senior Scientist Structural Biology & Rational Design | Structural Biologist Chemistry

World-Class Speaker Faculty Includes:

2024 Event Partners

Lead Partner

Expertise Partner

Expertise Partner

Expertise Partner

Expertise Partner

Expertise Partner

Exhibition Partner

Exhibition Partner

Event Partner

Companies Attending Include:

49604 - companies

“A great opportunity to see and discuss current approaches with industry leaders addressing challenging targets in a dynamic field”

Silvia Delker, Principal Scientist – Structural Biology & Project Manager, UCB

“Exchange experience in structure-based drug design. Network with colleagues working in related areas”

Yi Xing, Senior Director of Drug Creation, Head of Structural Biology & Rational Design, Seismic Therapeutic

“Insights into future trends in SBDD”

Felix Hausch, Professor, Structure-Based Drug Research, Technical University Darmstadt

“Networking with peers across industry and learning about the cutting-edge applications of the techniques in drug discovery”

Jason Cross, Institute Director – Structural & Computational Drug Design, MD Anderson Cancer Center

“Networking and understanding industry utilization of cryo-EM”

Andrew Ward, Professor – Integrative Structural & Computational Biology, The Scripps Research Institute

Events in the Series